Harvard Bioscience, Inc. HBI.F Stock
Harvard Bioscience, Inc. Price Chart
Harvard Bioscience, Inc. HBI.F Financial and Trading Overview
Harvard Bioscience, Inc. stock price | 3.96 EUR |
Previous Close | 5.3 EUR |
Open | 5.2 EUR |
Bid | 5 EUR x 240000 |
Ask | 5.05 EUR x 240000 |
Day's Range | 5.2 - 5.2 EUR |
52 Week Range | 1.96 - 5.65 EUR |
Volume | 500 EUR |
Avg. Volume | 116 EUR |
Market Cap | 219.85M EUR |
Beta (5Y Monthly) | 1.682746 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.07 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 10 EUR |
HBI.F Valuation Measures
Enterprise Value | 270.94M EUR |
Trailing P/E | N/A |
Forward P/E | 15.294117 |
PEG Ratio (5 yr expected) | 2.88 |
Price/Sales (ttm) | 1.9195215 |
Price/Book (mrq) | 2.9511917 |
Enterprise Value/Revenue | 2.366 |
Enterprise Value/EBITDA | 49.03 |
Trading Information
Harvard Bioscience, Inc. Stock Price History
Beta (5Y Monthly) | 1.682746 |
52-Week Change | 64.59% |
S&P500 52-Week Change | 20.43% |
52 Week High | 5.65 EUR |
52 Week Low | 1.96 EUR |
50-Day Moving Average | 4.79 EUR |
200-Day Moving Average | 3.15 EUR |
HBI.F Share Statistics
Avg. Volume (3 month) | 116 EUR |
Avg. Daily Volume (10-Days) | 149 EUR |
Shares Outstanding | 42.19M |
Float | 33.19M |
Short Ratio | N/A |
% Held by Insiders | 7.05% |
% Held by Institutions | 76.24% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -1.75% |
Operating Margin (ttm) | -1.67% |
Gross Margin | 56.27% |
EBITDA Margin | 4.82% |
Management Effectiveness
Return on Assets (ttm) | -0.79% |
Return on Equity (ttm) | -2.67% |
Income Statement
Revenue (ttm) | 114.53M EUR |
Revenue Per Share (ttm) | 2.75 EUR |
Quarterly Revenue Growth (yoy) | 4.20% |
Gross Profit (ttm) | 62.29M EUR |
EBITDA | 5.53M EUR |
Net Income Avi to Common (ttm) | -2014000 EUR |
Diluted EPS (ttm) | -0.05 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 3.79M EUR |
Total Cash Per Share (mrq) | 0.09 EUR |
Total Debt (mrq) | 51.12M EUR |
Total Debt/Equity (mrq) | 68.77 EUR |
Current Ratio (mrq) | 2.259 |
Book Value Per Share (mrq) | 1.762 |
Cash Flow Statement
Operating Cash Flow (ttm) | 4.95M EUR |
Levered Free Cash Flow (ttm) | 8.88M EUR |
Profile of Harvard Bioscience, Inc.
Country | Germany |
State | MA |
City | Holliston |
Address | 84 October Hill Road |
ZIP | 01746 |
Phone | 508 893 8999 |
Website | https://www.harvardbioscience.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 436 |
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services for life science applications in the United States and internationally. The company offers cellular and molecular technology products, such as syringe and peristaltic infusion pump products; electroporation and electrofusion instruments, amino acid analyzers, spectrophotometers, and other equipment for molecular level testing and research; and precision scientific measuring instrumentation and equipment, including data acquisition systems for cellular analysis, complete micro electrode array solutions for in vivo recordings, and in vitro systems for extracellular recordings. It also provides preclinical products that includes platform to assess physiological data from organisms for research, drug discovery, and drug development services comprising implantable and externally worn telemetry systems for use in research to collect cardiovascular, central nervous system, respiratory, and metabolic data; behavioral products; isolated organ and surgical products, instruments and accessories for tissue, and organ-based lab research, including surgical products, infusion systems, and behavior research systems; turn-key respiratory system solutions, including plethysmograph chambers, data acquisition hardware, physiological signal analysis software, and final report generation; inhalation and exposure systems; and GLP-capable data acquisition and analysis systems. The company markets its products through sales organizations, websites, and distributors to research scientists in pharmaceutical and biotechnology companies, universities, hospitals, and government laboratories; and contract research organizations and academic labs. It primarily sells its products under Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab brands. The company was founded in 1901 and is based in Holliston, Massachusetts.
Q&A For Harvard Bioscience, Inc. Stock
What is a current HBI.F stock price?
Harvard Bioscience, Inc. HBI.F stock price today per share is 3.96 EUR.
How to purchase Harvard Bioscience, Inc. stock?
You can buy HBI.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Harvard Bioscience, Inc.?
The stock symbol or ticker of Harvard Bioscience, Inc. is HBI.F.
Which industry does the Harvard Bioscience, Inc. company belong to?
The Harvard Bioscience, Inc. industry is Medical Instruments & Supplies.
How many shares does Harvard Bioscience, Inc. have in circulation?
The max supply of Harvard Bioscience, Inc. shares is 43.45M.
What is Harvard Bioscience, Inc. Price to Earnings Ratio (PE Ratio)?
Harvard Bioscience, Inc. PE Ratio is now.
What was Harvard Bioscience, Inc. earnings per share over the trailing 12 months (TTM)?
Harvard Bioscience, Inc. EPS is -0.07 EUR over the trailing 12 months.
Which sector does the Harvard Bioscience, Inc. company belong to?
The Harvard Bioscience, Inc. sector is Healthcare.